loadpatents
name:-0.0037310123443604
name:-0.00211501121521
name:-0.0014851093292236
Freeman; Gordon James Patent Filings

Freeman; Gordon James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Freeman; Gordon James.The latest application filed is for "method of detecting tim-3 using antibody molecules to tim-3".

Company Profile
8.11.20
  • Freeman; Gordon James - Brookline MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy
Grant 11,413,340 - Brogdon , et al. August 16, 2
2022-08-16
Method Of Detecting Tim-3 Using Antibody Molecules To Tim-3
App 20220185883 - Sabatos-Peyton; Catherine Anne ;   et al.
2022-06-16
Combination Therapies Comprising Antibody Molecules To Tim-3
App 20220133889 - Dranoff; Glenn ;   et al.
2022-05-05
Method of detecting TIM-3 using antibody molecules to TIM-3
Grant 11,155,620 - Sabatos-Peyton , et al. October 26, 2
2021-10-26
Antibody Molecules To Pd-l1 And Uses Thereof
App 20210284737 - Freeman; Gordon James ;   et al.
2021-09-16
Antibody molecules to TIM-3 and uses thereof
Grant 10,981,990 - Sabatos-Peyton , et al. April 20, 2
2021-04-20
Antibody molecules to PD-L1 and methods of treating cancer
Grant 10,851,165 - Freeman , et al. December 1, 2
2020-12-01
Antibody Molecules To Pd-1 And Uses Thereof
App 20200339689 - Freeman; Gordon James ;   et al.
2020-10-29
Antibody Molecules To Tim-3 And Uses Thereof
App 20200308277 - Sabatos-Peyton; Catherine Anne ;   et al.
2020-10-01
Antibody molecules to PD-1 and uses thereof
Grant 10,752,687 - Freeman , et al. A
2020-08-25
Antibody Molecules To Tim-3 And Uses Thereof
App 20200223917 - Sabatos-Peyton; Catherine Anne ;   et al.
2020-07-16
Antibody molecules to TIM-3 and uses thereof
Grant 10,472,419 - Sabatos-Peyton , et al. Nov
2019-11-12
Mesothelin Chimeric Antigen Receptor (car) And Antibody Against Pd-l1 Inhibitor For Combined Use In Anticancer Therapy
App 20190000944 - Brogdon; Jennifer ;   et al.
2019-01-03
Combination Therapies Comprising Antibody Molecules To Pd-1
App 20180222982 - Dranoff; Glenn ;   et al.
2018-08-09
Combination Therapies Comprising Antibody Molecules To Tim-3
App 20180207273 - Dranoff; Glenn ;   et al.
2018-07-26
Antibody Molecules To Pd-l1 And Uses Thereof
App 20180186882 - Freeman; Gordon James ;   et al.
2018-07-05
Antibody Molecules To Pd-1 And Uses Thereof
App 20180155427 - Freeman; Gordon James ;   et al.
2018-06-07
Antibody molecules to PD-L1 and uses thereof
Grant 9,988,452 - Freeman , et al. June 5, 2
2018-06-05
Antibody molecules to TIM-3 and uses thereof
Grant 9,884,913 - Sabatos-Peyton , et al. February 6, 2
2018-02-06
Antibody molecules to PD-1 and uses thereof
Grant 9,815,898 - Freeman , et al. November 14, 2
2017-11-14
Antibody Molecules To Pd-1 And Uses Thereof
App 20170247456 - Freeman; Gordon James ;   et al.
2017-08-31
Antibody Molecules To Tim-3 And Uses Thereof
App 20170198041 - Sabatos-Peyton; Catherine Anne ;   et al.
2017-07-13
Antibody Molecules To Tim-3 And Uses Thereof
App 20170190777 - Sabatos-Peyton; Catherine Anne ;   et al.
2017-07-06
Antibody molecules to PD-1 and uses thereof
Grant 9,683,048 - Freeman , et al. June 20, 2
2017-06-20
Antibody molecules to TIM-3 and uses thereof
Grant 9,605,070 - Sabatos-Peyton , et al. March 28, 2
2017-03-28
Antibody Molecules To Pd-l1 And Uses Thereof
App 20160108123 - Freeman; Gordon James ;   et al.
2016-04-21
Antibody Molecules To Tim-3 And Uses Thereof
App 20150218274 - Sabatos-Peyton; Catherine Anne ;   et al.
2015-08-06
Antibody Molecules To Pd-1 And Uses Thereof
App 20150210769 - Freeman; Gordon James ;   et al.
2015-07-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed